Some of them even had normal LDL-C levels, occasionally induced by a combination of a pathogenic and a favorable ‘counter’ mutation, causing hypobetalipoproteinemia, Proprotein convertase subtilisin/kexin type 9 (PCSK9) loss of function or hyperalphalipoproteinemia. The gene discussed is PCSK9; the disease is hypobetalipoproteinemia.